EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Impact of COVID-19 on Cardiovascular Disease

Ivan Vosko iD, Andreas Zirlik, Heiko Bugger

Viruses · 11.02.2023 · 15 (2) · 508

DOI: 10.3390/v15020508 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 11.02.2023. Verfasst von Ivan Vosko und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Medical University of Graz, 8036 Graz, Austria. Hauptthemen laut MEDLINE: Cardiovascular Diseases, COVID-19, Heart Failure. Die Arbeit wurde bisher 114-mal zitiert (Crossref) und nennt 243 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Cardiologic Society, Austrian Science Fund, Austrian Diabetes Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronavirus disease 2019 (COVID-19) is a viral infection with the novel severe acute respiratory distress syndrome corona virus 2 (SARS-CoV-2). Until now, more than 670 million people have suffered from COVID-19 worldwide, and roughly 7 million death cases were attributed to COVID-19. Recent evidence suggests an interplay between COVID-19 and cardiovascular disease (CVD). COVID-19 may serve as a yet underappreciated CVD risk modifier, including risk factors such as diabetes mellitus or arterial hypertension. In addition, recent data suggest that previous COVID-19 may increase the risk for many entities of CVD to an extent similarly observed for traditional cardiovascular (CV) risk factors. Furthermore, increased CVD incidence and worse clinical outcomes in individuals with preexisting CVD have been observed for myocarditis, acute coronary syndrome, heart failure (HF), thromboembolic complications, and arrhythmias. Direct and indirect mechanisms have been proposed by which COVID-19 may impact CVD and CV risk, including viral entry into CV tissue or by the induction of a massive systemic inflammatory response. In the current review, we provide an overview of the literature reporting an interaction between COVID-19 and CVD, review potential mechanisms underlying this interaction, and discuss preventive and treatment strategies and their interference with CVD that were evaluated since the onset of the COVID-19 pandemic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesCOVID-19Heart FailureHumansPandemicsSARS-CoV-2

Stichwörter der Autor:innen

COVID-19SARS-CoV-2cardiovascular disease

Autor:innen und Institutionen

  • Department of Cardiology, Medical University of Graz, 8036 Graz, Austria.

ORCID-Profile: Ivan Vosko

Förderung

  • Austrian Cardiologic Society
  • Austrian Science Fund
  • Austrian Diabetes Association

Zitieren

APA

Vosko, I., Zirlik, A., & Bugger, H. (2023). Impact of COVID-19 on Cardiovascular Disease. Viruses, 15(2), 508. https://doi.org/10.3390/v15020508

Vancouver

Vosko I, Zirlik A, Bugger H. Impact of COVID-19 on Cardiovascular Disease. Viruses. 2023;15(2):508. doi:10.3390/v15020508

BibTeX
@article{Vosko2023,
  author = {Vosko, Ivan and Zirlik, Andreas and Bugger, Heiko},
  title = {Impact of COVID-19 on Cardiovascular Disease},
  journal = {Viruses},
  year = {2023},
  volume = {15},
  number = {2},
  pages = {508},
  doi = {10.3390/v15020508}
}
Kostenlos starten →